Buerger’s disease: providing integrated care

References

• WiniwarterFUeber eine eigenthümliche Form von Endarteriitis und Endophlebitis mit Gangrän des Fußes [About a strange kind of endarteriitis and endophlebitis with gangrene of the foot]Arch Klin Chir187923202226 quoted according to ref. 39
   Google Scholar
• BuergerLLandmark publication from the American Journal of the Medical Sciences,’ Thrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene’. 1908Am J Med Sci2009337427428419365174
   PubMed Web of Science ®Google Scholar
• DargonPTLandryGJBuerger’s diseaseAnn Vasc Surg201226687188022284771
   PubMed Web of Science ®Google Scholar
• OlinJWThromboangiitis obliterans (Buerger’s disease)N Engl J Med20003431286486910995867
   PubMed Web of Science ®Google Scholar
• PiazzaGCreagerMAThromboangiitis obliteransCirculation2010121161858186120421527
   PubMed Web of Science ®Google Scholar
• PuéchalXFiessingerJNThromboangiitis obliterans or Buerger’s disease: challenges for the rheumatologistRheumatology (Oxford)200746219219917116654
   PubMed Web of Science ®Google Scholar
• HidaNOhtaTCurrent status of patients with Buerger disease in JapanAnn Vasc Dis20136361762324130618
   PubMedGoogle Scholar
• LieJTThe rise and fall and resurgence of thromboangiitis obliterans (Buerger’s disease)Acta Pathol Jpn19893931531582662703
   PubMedGoogle Scholar
• SasakiSSakumaMKuniharaTYasudaKCurrent trends in thromboangiitis obliterans (Buerger’s disease) in womenAm J Surg1999177431632010326851
   PubMed Web of Science ®Google Scholar
• ArkkilaPEThromboangiitis obliterans (Buerger’s disease)Orphanet J Rare Dis200611416722538
   PubMed Web of Science ®Google Scholar
• AdarREpidemiology of TAO – correction of an errorAtherosclerosis201021112420167322
   PubMed Web of Science ®Google Scholar
• MatsushitaMNishikimiNSakuraiTNimuraYDecrease in prevalence of Buerger’s disease in JapanSurgery199812434985029736901
   PubMed Web of Science ®Google Scholar
• OlinJWYoungJRGraorRARuschhauptWFBartholomewJRThe changing clinical spectrum of thromboangiitis obliterans (Buerger’s disease)Circulation1990825 supplIV3IV82225420
   PubMed Web of Science ®Google Scholar
• FazeliBBuerger’s disease as an indicator of socioeconomic development in different societies, a cross-sectional descriptive study in the North-East of IranArch Med Sci20106334334722371769
   PubMed Web of Science ®Google Scholar
• McLoughlinGAHelsbyCREvansCCChapmanDMAssociation of HLA-A9 and HLA-B5 with Buerger’s diseaseBr Med J19762604511651166990826
   PubMed Web of Science ®Google Scholar
• AerbajinaiWTsuchiyaTKimuraAYasukochiYNumanoFHLA class II DNA typing in Buerger’s diseaseInt J Cardiol199654supplS197S2029119524
   PubMed Web of Science ®Google Scholar
• OtawaTJugiTKawanoNMishimaYToyamaHLetter: HL-A antigens in thromboangiitis obliteransJAMA1974230811284479437
   PubMed Web of Science ®Google Scholar
• NumanoFSasazukiTKoyamaTHLA in Buerger’s diseaseExp Clin Immunogenet1986341952003274054
   PubMedGoogle Scholar
• KimuraAKobayashiYTakahashiMMICA gene polymorphism in Takayasu’s arteritis and Buerger’s diseaseInt J Cardiol199866suppl 1S107S1139951809
   PubMed Web of Science ®Google Scholar
• MehraNKJainiRImmunogenetics of peripheral arteriopathiesClin Hemorheol Microcirc2000232–422523211321444
   PubMed Web of Science ®Google Scholar
• AdigüzelYYilmazEAkarNEffect of eNOS and ET-1 polymorphisms in thromboangiitis obliteransClin Appl Thromb Hemost201016110310619520685
   PubMed Web of Science ®Google Scholar
• ChenZNakajimaTInoueYA single nucleotide polymorphism in the 3′-untranslated region of MyD88 gene is associated with Buerger disease but not with Takayasu arteritis in JapaneseJ Hum Genet201156754554721525878
   PubMed Web of Science ®Google Scholar
• PavlicVVujic-AleksicVZubovicNGojkov-VukelicMPeriodontitis and Buerger’s disease: recent advancesActa Inform Med201321425025224554799
   PubMedGoogle Scholar
• IwaiTPeriodontal bacteremia and various vascular diseasesJ Periodontal Res200944668969419874452
   PubMed Web of Science ®Google Scholar
• FazeliBRafatpanahHRavariHHosseiniRFRezaeeSAInvestigation of the expression of mediators of neovascularization from mononuclear leukocytes in thromboangiitis obliteransVascular201422317418023567329
   PubMed Web of Science ®Google Scholar
• GulatiSMAgarwalVSharmaVSahaKC3 complement components & their breakdown product (C3d) in patients of thromboangiitis obliteransIndian J Med Res1986846076113494676
   PubMed Web of Science ®Google Scholar
• HalachevaKGulubovaMVManolovaIPetkovDExpression of ICAM-1, VCAM-1, E-selectin and TNF-alpha on the endothelium of femoral and iliac arteries in thromboangiitis obliteransActa Histochem2002104217718412086338
   PubMed Web of Science ®Google Scholar
• KimEJChoBSLeeTSKimSJSeoJWMorphologic change of the internal elastic lamina in Buerger’s diseaseJ Korean Med Sci2000151444810719807
   PubMed Web of Science ®Google Scholar
• KobayashiMItoMNakagawaANishikimiNNimuraYImmunohistochemical analysis of arterial wall cellular infiltration in Buerger’s disease (endarteritis obliterans)J Vasc Surg199929345145810069909
   PubMed Web of Science ®Google Scholar
• LeeTSeoJWSumpioBEKimSJImmunobiologic analysis of arterial tissue in Buerger’s diseaseEur J Vasc Endovasc Surg200325545145712713785
   PubMed Web of Science ®Google Scholar
• Dellalibera-JovilianoRJovilianoEESilvaJSEvoraPRActivation of cytokines corroborate with development of inflammation and autoimmunity in thromboangiitis obliterans patientsClin Exp Immunol20121701283522943198
   PubMed Web of Science ®Google Scholar
• SlavovESStanilovaSAPetkovDPDobrevaZGCytokine production in thromboangiitis obliterans patients: new evidence for an immune-mediated inflammatory disorderClin Exp Rheumatol200523221922615895893
   PubMed Web of Science ®Google Scholar
• De GodoyJMBraileDMGodoyMFBuerger’s disease and anticardiolipin antibodies: a worse prognosis?Clin Appl Thromb Hemost200281858611991245
   PubMed Web of Science ®Google Scholar
• EichhornJSimaDLindschauCAntiendothelial cell antibodies in thromboangiitis obliteransAm J Med Sci1998315117239427570
   PubMed Web of Science ®Google Scholar
• GulatiSMMadhraKThusooTKNairSKSahaKAutoantibodies in thromboangiitis obliterans (Buerger’s disease)Angiology198233106426516751163
   PubMed Web of Science ®Google Scholar
• HalachevaKSManolovaIMPetkovDPAndreevAPStudy of anti-neutrophil cytoplasmic antibodies in patients with thromboangiitis obliterans (Buerger’s disease)Scand J Immunol19984855445509822265
   PubMed Web of Science ®Google Scholar
• OlinJWAre anticardiolipin antibodies really important in thromboangiitis obliterans (Buerger’s disease)?Vasc Med20027425725812710839
   PubMed Web of Science ®Google Scholar
• Pereira de GodoyJMBraileDMBuerger’s disease and anticardiolipin antibodiesJ Cardiovasc Med (Hagerstown)2009101079279419455050
   PubMed Web of Science ®Google Scholar
• SmolenJSYoungchaiyudUWeidingerPAutoimmunological aspects of thromboangiitis obliterans (Buerger’s disease)Clin Immunol Immunopathol1978112168177367656
   PubMedGoogle Scholar
• Klein-WeigelPFBimmlerMHempelPPattern of G-protein coupled receptor auto-antibodies in thromboangiitis obliterans (Buerger’s disease) and their removal by immunoadsorptionVasa201443534735225147011
   PubMed Web of Science ®Google Scholar
• KethaSSCooperLTThe role of autoimmunity in thromboangiitis obliterans (Buerger’s disease)Ann N Y Acad Sci20131285152523510296
   PubMed Web of Science ®Google Scholar
• FarberowNLNehemkisAMIndirect self-destructive behavior in patients with Buerger’s diseaseJ Pers Assess19794318696430334
   PubMed Web of Science ®Google Scholar
• DiehmCSchäferMDas Buerger-Syndrom (Thrombangiitis obliterans) Geschichte, Epidemiologie, Pathologie, Klinik, Diagnostik und Therapie [The Buerger’s syndrome (thrombangiitis obliterans) History, epidemiology, pathology, clinic, diagnostic, and therapy]Berlin; Heidelberg; New YorkSpringer Verlag1993
   Google Scholar
• ShionoyaSDiagnostic criteria of Buerger’s diseaseInt J Cardiol198866suppl 1S243S245
   Google Scholar
• Klein-WeigelPFRichterJGThromboangiitis obliterans (Buerger’s disease)Vasa201443533734625147010
   PubMed Web of Science ®Google Scholar
• SasakiSSakumaMKuniharaTYasudaKDistribution of arterial involvement in thromboangiitis obliterans (Buerger’s disease): results of a study conducted by the Intractable Vasculitis Syndromes Research Group in JapanSurg Today200030760060510930225
   PubMed Web of Science ®Google Scholar
• ShionoyaSBanINakataYMatsubaraJHiraiMKawaiSInvolvement of the iliac artery in Buerger’s disease (pathogenesis and arterial reconstruction)J Cardiovasc Surg (Torino)19781916976
   Web of Science ®Google Scholar
• WysokinskiWEKwiatkowskaWMaslowskiLWitkiewiczWKowal-GierczakBBuerger’s disease in two brothers: iliac artery occlusion by thromboangiitis obliterans-case reportsAngiology19984954094149591534
   PubMed Web of Science ®Google Scholar
• BecitNUnlüYKoçakHCevizMInvolvement of the coronary artery in a patient with thromboangiitis obliterans. A case reportHeart Vessels200216520120312181595
   PubMed Web of Science ®Google Scholar
• CalgüneriMOztürkMAAyHBuerger’s disease with multisystem involvement. A case report and a review of the literatureAngiology200455332532815156267
   PubMed Web of Science ®Google Scholar
• DrakeMEJrWiniwarter-Buerger disease (‘thromboangiitis obliterans’) with cerebral involvementJAMA198224815187018727120607
   PubMed Web of Science ®Google Scholar
• HartenPMüller-HuelsbeckSRegensburgerDLoefflerHMultiple organ manifestations in thromboangiitis obliterans (Buerger’s disease). A case reportAngiology19964744194258619517
   PubMed Web of Science ®Google Scholar
• SiddiquiMZReisEDSoundararajanKKersteinMDBuerger’s disease affecting mesenteric arteries: a rare cause of intestinal ischemia – a case reportVasc Surg200135323523811452353
   PubMedGoogle Scholar
• FazeliBModagheghHRavraiHKazemzadehGThrombophlebitis migrans as a footprint of Buerger’s disease: a prospective-descriptive study in north-east of IranClin Rheumatol2008271555717554578
   PubMed Web of Science ®Google Scholar
• FagrellBLundbergGA simplified evaluation of vital capillary microscopy for predicting skin viability in patients with severe arterial insufficiencyClin Physiol1984454034116541549
   PubMedGoogle Scholar
• RanftJLammersenTHeidrichHIn-vivo capillary-microscopical findings in patients with thromboangiitis obliterans, progressive systemic scleroderma, and rheumatoid arthritis, respectivelyKlin Wochenschr198664199469503784444
   PubMedGoogle Scholar
• LawrencePFLundOIJimenezJCMuttalibRSubstitution of smokeless tobacco for cigarettes in Buerger’s disease does not prevent limb lossJ Vasc Surg200848121021218589234
   PubMed Web of Science ®Google Scholar
• LieJTThromboangiitis obliterans (Buerger’s disease) and smokeless tobaccoArthritis Rheum19883168128133382454
   PubMed Web of Science ®Google Scholar
• CooperLTHendersonSSBallmanKVA prospective, case-control study of tobacco dependence in thromboangiitis obliterans (Buerger’s Disease)Angiology2006571737816444459
   PubMed Web of Science ®Google Scholar
• HootenWMBrunsHKHaysJTInpatient treatment of severe nicotine dependence in a patient with thromboangiitis obliterans (Buerger’s disease)Mayo Clin Proc19987365295329621859
   PubMed Web of Science ®Google Scholar
• Jiménez-RuizCADaleLCAstray MochalesJVelázquez BuendíaLde Granda OriveIGuirao GarcíaASmoking characteristics and cessation in patients with thromboangiitis obliteransMonaldi Arch Chest Dis200665421722117393667
   PubMedGoogle Scholar
• BalmfordJLeifertJASchulzCElzeMJaehneAImplementation and effectiveness of a hospital smoking cessation service in GermanyPatient Educ Couns201494110310924176610
   PubMed Web of Science ®Google Scholar
• RigottiNAMunafoMRSteadLFInterventions for smoking cessation in hospitalized patientsCochrane Database Syst Rev20073CD00183717636688
   PubMed Web of Science ®Google Scholar
• KhatiIMenvielleGCholletAYounèsNMetadieuBMelchiorMWhat distinguishes successful from unsuccessful tobacco smoking cessation? Data from a study of young adults (TEMPO)Prev Med Rep2015267968526844137
   PubMedGoogle Scholar
• FiessingerJNSchäferMTrial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO StudyLancet199033586895555571689791
   PubMed Web of Science ®Google Scholar
• The European TAO Study GroupOral iloprost in the treatment of thromboangiitis obliterans (Buerger’s disease): a double-blind, randomised, placebo-controlled trialEur J Vasc Endovasc Surg19981543003079610341
   PubMed Web of Science ®Google Scholar
• BozkurtAKKöksalCDemirbasMYA randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the management of Buerger’s diseaseInt Angiol200625216216816763533
   PubMed Web of Science ®Google Scholar
• BozkurtAKCengizKArslanCA stable prostacyclin analogue (iloprost) in the treatment of Buerger’s disease: a prospective analysis of 150 patientsAnn Thorac Cardiovasc Surg201319212012522971807
   PubMed Web of Science ®Google Scholar
• CacioneDGBaptista-SilvaJCMacedoCRPharmacological treatment for Buerger’s diseaseCochrane Database Syst Rev20162CD011033 Update in: Cochrane Database Syst Rev. 2016;3:CD01103326828199
   PubMed Web of Science ®Google Scholar
• HashimotoAItoHSatoYFujiwaraYAutomated intermittent bolus infusion for continuous sciatic nerve block: a case reportMasui201160787387521800674
   PubMedGoogle Scholar
• ParaskevasKITrigkaAASamaraMSuccessful intravenous regional sympathetic blockade (Bier’s Block) with guanethidine and lidocaine in a patient with advanced Buerger’s Disease (thromboangiitis obliterans)-a case reportAngiology200556449349616079935
   PubMed Web of Science ®Google Scholar
• SaddlerJMCrosseMMIschaemic pain in Buerger’s disease. Report of a female patient receiving long-term local analgesiaAnaesthesia19884343053062454039
   PubMed Web of Science ®Google Scholar
• DonasKPSchulteSKtenidisKHorschSThe role of epidural spinal cord stimulation in the treatment of Buerger’s diseaseJ Vasc Surg200541583083615886668
   PubMed Web of Science ®Google Scholar
• Vaquer QuillsLBlasco GonzálezLAsensio SamperJVillanueva PérezVLLópez AlarcónMDDe Andrés IbáñezJEpidural neuro-stimulation of posterior funiculi for the treatment of Buerger’s diseaseNeuromodulation200912215616022151290
   PubMed Web of Science ®Google Scholar
• InadaKIwashimaYOkadaAMatsumotoKNonatherosclerotic segmental arterial occlusion of the extremityArch Surg197410856636674829784
   PubMedGoogle Scholar
• SayinABozkurtAKTüzünHVuralFSErdogGOzerMSurgical treatment of Buerger’s disease: experience with 216 patientsCardiovasc Surg1993143773808076063
   PubMedGoogle Scholar
• ShionoyaSBanINakataYMatsubaraJHiraiMKawaiSSurgical treatment of Buerger’s diseaseJ Cardiovasc Surg (Torino)19802117784
   PubMed Web of Science ®Google Scholar
• SasajimaTKuboYInabaMGohKAzumaNRole of infrainguinal bypass in Buerger’s disease: an eighteen-year experienceEur J Vasc Endovasc Surg19971321861929091153
   PubMed Web of Science ®Google Scholar
• KawaradaOAyabeSYotsukuraHSubintimal angioplasty of lengthy femorotibial total occlusion in Buerger’s diseaseJ Endovasc Ther201320457858123914872
   PubMed Web of Science ®Google Scholar
• GrazianiLMorelliLPariniFClinical outcome after extended endovascular recanalization in Buerger’s disease in 20 consecutive casesAnn Vasc Surg201226338739522285343
   PubMed Web of Science ®Google Scholar
• SandnerTADegenhartCBecker-LienauJReiserMFTreitlMTherapie peripherer Gefäßstenosen und –verschlüsse bei Thrombangiitis obliterans [Therapy of peripheral vessel stenosis and occlusion in patients with thromboangiitis obliterans]Radiologe20105010887893 German20717643
   PubMed Web of Science ®Google Scholar
• HodgsonTJGainesPABeardJDThrombolysis and angioplasty for acute lower limb ischemia in Buerger’s diseaseCardiovasc Intervent Radiol19941763333357882401
   PubMed Web of Science ®Google Scholar
• BozkurtAKBeşirliKKöksalCSurgical treatment of Buerger’s diseaseVascular200412319219715586528
   PubMedGoogle Scholar
• SahaKChabraNGulatiSMTreatment of patients with thromboangiitis obliterans with cyclophosphamideAngiology200152639940711437030
   PubMed Web of Science ®Google Scholar
• Gur’evaMSBaranovAABagrakovaSVKurdiukovAAPul’s-terapiia gliukokortikoidami i tsiklofosfamidom v lechenii obliteriruiushchego trombangiita [Pulse-therapy with glucocorticoids and cyclophosphamide in the treatment of thromboangiitis obliterans]Klin Med (Mosk)200381105357 Russian
   Google Scholar
• BodaZUdvardyMRázsóKStem cell therapy: a promising and prospective approach in the treatment of patients with severe Buerger’s diseaseClin Appl Thromb Hemost200915555256018818231
   PubMed Web of Science ®Google Scholar
• DurduSAkarARAratMSancakTErenNTOzyurdaUAutologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II–III thromboangiitis obliteransJ Vasc Surg200644473273916926085
   PubMed Web of Science ®Google Scholar
• LawallHBramlagePAmannBTreatment of peripheral arterial disease using stem and progenitor cell therapyJ Vasc Surg201153244545321030198
   PubMed Web of Science ®Google Scholar
• LeeKBKangESKimAKStem cell therapy in patients with thromboangiitis obliterans: assessment of the long-term clinical outcome and analysis of the prognostic factorsInt J Stem Cells201142889824298340
   PubMedGoogle Scholar
• MotukuruVSureshKRVivekanandVRajSGirijaKRTherapeutic angiogenesis in Buerger’s disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cellsJ Vasc Surg2008486 suppl53S60S19084740
   PubMed Web of Science ®Google Scholar
• TeraaMSprengersRWvan der GraafYPetersCEMollFLVerhaarMCAutologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trialsAnn Surg2013258692292923426345
   PubMed Web of Science ®Google Scholar
• BenoitEO’DonnellTFPatelANSafety and efficacy of autologous cell therapy in critical limb ischemia: a systematic reviewCell Transplant201322354556222490340
   PubMed Web of Science ®Google Scholar
• KinoshitaMFujitaYKatayamaMLong-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemiaAtherosclerosis2012224244044522877866
   PubMed Web of Science ®Google Scholar
• MatobaSTatsumiTMuroharaTLong-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemiaAm Heart J200815651010101819061721
   PubMed Web of Science ®Google Scholar
• MoriyaJMinaminoTTatenoKLong-term outcome of therapeutic neovascularization using peripheral blood mononuclear cells for limb ischemiaCirc Cardiovasc Interv20092324525420031722
   PubMed Web of Science ®Google Scholar
• AmannBLuedemannCRateiRSchmidt-LuckeJAAutologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery diseaseCell Transplant200918337138019500466
   PubMed Web of Science ®Google Scholar
• InanMAlatIKutluRHarmaAGermenBSuccessful treatment of Buerger’s Disease with intramedullary K-wire: the results of the first 11 extremitiesEur J Vasc Endovasc Surg200529327728015694801
   PubMed Web of Science ®Google Scholar
• KimDIKimMJJohJHAngiogenesis facilitated by autologous whole bone marrow stem cell transplantation for Buerger’s diseaseStem Cells20062451194120016439614
   PubMed Web of Science ®Google Scholar
• PatwaJJKrishnanABuerger’s disease (thromboangiitis obliterans)-management by ilizarov’s technique of horizontal distraction. A retrospective study of 60 casesIndian J Surg2011731404722211037
   PubMed Web of Science ®Google Scholar
• BaumannGStanglVKlein-WeigelPStanglKLauleMEnke-MelzerKSuccessful treatment of thromboangiitis obliterans (Buerger’s disease) with immunoadsorption: results of a pilot studyClin Res Cardiol2011100868369021380608
   PubMed Web of Science ®Google Scholar
• Klein-WeigelPKöningCHärtwigAImmunadsorption bei Thrombangiitis obliterans – eine vielversprechende therapeutische Option. Behandlungsergebnisse einer konsekutiven Patientenkohorte in der klinischen Routineversorgung [Immunoadsorption in thromboangiitis obliterans: a promising therapeutic option: results of a consecutive patient cohort treated in clinical routine care]Zentralbl Chir20121375460465 German23136105
   PubMed Web of Science ®Google Scholar
• Klein-WeigelPFBimmlerMHempelPPattern of G-protein coupled receptor auto-antibodies in thromboangiitis obliterans (Buerger’s disease) and their removal by immunoadsorptionVasa201443534735225147011
   PubMed Web of Science ®Google Scholar
• Todoli ParraJAHernándezMMArrébola LópezMAEfficacy of bosentan in digital ischemic ulcersAnn Vasc Surg2010245690.e1690.e4
   Web of Science ®Google Scholar
• De HaroJAcinFBledaSVarelaCEsparzaLTreatment of thromboangiitis obliterans (Buerger’s disease) with bosentanBMC Cardiovasc Disord201212522333218
   PubMed Web of Science ®Google Scholar
• BörnerCHeidrichHLong-term follow-up of thromboangiitis obliteransVasa199827280869612110
   PubMed Web of Science ®Google Scholar
• MyerSACase studies: what a difference a nurse makesAACN Clin Issues1995645765877493261
   PubMedGoogle Scholar
• Frost-RudeJANunneleeJDSpanerSBuerger’s diseaseJ Vasc Nurs200018412813011995294
   PubMedGoogle Scholar